Health Ministry Proposes One-Year Minimum Residual Shelf Life for Imported Drugs
The Union Health Ministry has proposed a draft amendment requiring imported drugs to have a minimum residual shelf life of 12 months upon entry, replacing the current rule of over 60% of total shelf life. This change aims to enhance pharmaceutical supply chain efficiency, reduce medicine wastage, and ensure patients receive drugs with adequate usable shelf life. The existing requirement remains for biological products and radiopharmaceuticals due to their specialized nature. The proposal is open for public consultation.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. Coverage leans balanced overall (Left 2%, Centre 97%, Right 1%). Overall sentiment is positive (69/100). Lens Score 30/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- businessstandard— balanced framing, positive sentiment
- economictimes— balanced framing, positive sentiment
- thetribune— balanced framing, positive sentiment
- news18— balanced framing, neutral sentiment
AI Analysis
The article group presents a government policy proposal focused on regulatory amendments without partisan framing. Coverage centers on official statements from the Health Ministry, emphasizing administrative and public health perspectives. There is no evident political opposition or alternative viewpoints included, reflecting a neutral, policy-focused narrative.
The overall tone across the articles is neutral to positive, highlighting the intended benefits of the proposed amendment such as improved supply chain efficiency and reduced wastage. The language is factual and descriptive, with no critical or negative sentiment expressed, focusing on the potential advantages for patients and the pharmaceutical sector.
How 4 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.